News for Jazz Pharmaceuticals plc (JAZZN.MX)

Total Annual Revenue: Over $4 billion for 2024.Fourth Quarter Revenue: Nearly $1.1 billion, highest ever for the company.Adjusted Net Income (Non-GAAP): $1.37

Feb 25, 2025 / 09:30PM GMTOperator Thank you for standing by. My name is Jeannie, and I will be your conference operator today. At this time, I would like to we

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q4 2024 Earnings Conference Call February 25, 2025 4:30 PM ETCompany ParticipantsJeff Macdonald - Executive Director,...

The following slide deck was published by Jazz Pharmaceuticals plc in conjunction with their 2024 Q4 earnings call.

Jazz Pharmaceuticals PLC (JAZZ) announced its financial results for the full year and fourth quarter of 2024, reporting record total revenues of $4.1 billion, a

PR NewswireDUBLIN, Feb. 25, 2025 ”“ Record total revenues of $4.1 billion in 2024 and $1.1 billion in 4Q24 ”“”“ Xywav® and Epidiolex® revenues grew 16

Revenue: Achieved record total revenues of $4.1 billion for 2024, surpassing the annual estimate of $4.04 billion.Quarterly Revenue: Fourth quarter revenue rea

Jazz Pharmaceuticals PLC (JAZZ), a leading global biopharmaceutical company, announced on February 20, 2025, that it will participate in TD Cowen's 45th Annual

On December 31, 2024, Vestal Point Capital, LP (Trades, Portfolio) executed a significant transaction involving Applied Therapeutics Inc (APLT). The firm added

Vestal Point Capital, LP (Trades, Portfolio), a prominent investment firm, recently made a significant adjustment to its holdings in uniQure NV. On December 31,

On December 31, 2024, Vestal Point Capital, LP (Trades, Portfolio), a prominent investment firm, executed a noteworthy transaction by acquiring an additional 2,

On December 31, 2024, Vestal Point Capital, LP (Trades, Portfolio), a prominent investment firm, executed a significant transaction by acquiring 2,924,216 share

EcoR1 Capital, LLC (Trades, Portfolio), a prominent investment firm, recently executed a substantial reduction in its holdings of AlloVir Inc (ALVR) shares. On

EcoR1 Capital, LLC (Trades, Portfolio), a prominent investment firm, recently expanded its holdings in Eton Pharmaceuticals Inc by acquiring an additional 583,3

EcoR1 Capital, LLC (Trades, Portfolio), a prominent investment firm, recently made a strategic decision to reduce its holdings in Atea Pharmaceuticals Inc (AVIR

EcoR1 Capital, LLC (Trades, Portfolio)'s Recent Transaction with HOOKIPA Pharma Inc On December 31, 2024, EcoR1 Capital, LLC (Trades, Portfolio) executed a sign

EcoR1 Capital, LLC (Trades, Portfolio), a prominent investment firm, recently executed a significant transaction involving Aadi Bioscience Inc. On December 31,

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

Summary On February 6, 2025, Jazz Pharmaceuticals PLC (JAZZ) announced its participation in the Union for International Cancer Control's Upside Down Challenge a